Kavitha Ganesh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kavitha Ganesh has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Mary Anne Wong Cordero
Department of Basic Health Sciences, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia
2 shared publications - Ajay Chandrasekar V S
Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India
1 shared publication - Alok Shiomurti Tripathi
Department of Pharmacology, Era College of Pharmacy, ERA University, Lucknow, Uttar Pradesh, India
1 shared publication - Ashni Bhandari
Surya College of Pharmacy, Villupuram, Tamil Nadu, India
1 shared publication - Krishna Prasanth Baalann
Bharath Institute of Higher Education and Research, Chennai, India
1 shared publication - Lucy Mohapatra
Amity Institute of Pharmacy, Amity University Uttar Pradesh, Lucknow Campus, Lucknow 226028, UP, India
1 shared publication
Latest Publications
- Open Access
- 30 June 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (2) , 1553
Tri-lineage Differentiation and Secretome Analylsis of FBS and LHPL Supplemented hUCT-MSCs - A Comparative Evaluation on ISCT Criteria
With advancements in regenerative medicine based on human umbilical cord tissue derived mesenchymal stem cells (hUCT-MSCs) plays major role in clinical trials on tissue engineering and cell therapies to a variety of diseases like ischemia, diabetes, bone, cartilage and neurological disorders. Presently the gold standard supplement in culturing hUCT-MSC is foetal bovine serum (FBS), obtained in an unscrupulous way from the foetus of cow. Being a xenogeneic supplement, FBS increases the risk of zoonotic infection transmission and unfavourable immunological reactions in patients after transplantation. Also it is high on demand and with ethical issues. According to International Society for Cellular Therapy (ISCT) a supplement of culture media for hUCT-MSC must possess a few qualities like tri-lineage differentiation and must secrete certain cytokines with a zoonotic free environment and so called to find a human derived supplement alternate. Human platelet lysate (HPL) was considered a better supplement in culturing hUCT-MSCs but it can’t be stored in normal temperature nor reconstituted in time as it needed freezing thawing cycles. New researches saying that lyophilized human platelet lysate (LHPL) can be an effective alternate as it can be stored and reconstituted without zoonotic infections. So we have formulated this study so as to evaluate the potency of LHPL in fulfilling the ISCT criteria on proliferation, tri-lineage differentiation and on secretomes as a supplement in culturing hUCT-MSCs.
- 30 June 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (2) , 1553
Open AccessTri-lineage Differentiation and Secretome Analylsis of FBS and LHPL Supplemented hUCT-MSCs - A Comparative Evaluation on ISCT Criteria
With advancements in regenerative medicine based on human umbilical cord tissue derived mesenchymal stem cells (hUCT-MSCs) plays major role in clinical trials on tissue engineering and cell therapies to a variety of diseases like ischemia, diabetes, bone, cartilage and neurological disorders. Presently the gold standard supplement in culturing hUCT-MSC is foetal bovine serum (FBS), obtained in an unscrupulous way from the foetus of cow. Being a xenogeneic supplement, FBS increases the risk of zoonotic infection transmission and unfavourable immunological reactions in patients after transplantation. Also it is high on demand and with ethical issues. According to International Society for Cellular Therapy (ISCT) a supplement of culture media for hUCT-MSC must possess a few qualities like tri-lineage differentiation and must secrete certain cytokines with a zoonotic free environment and so called to find a human derived supplement alternate. Human platelet lysate (HPL) was considered a better supplement in culturing hUCT-MSCs but it can’t be stored in normal temperature nor reconstituted in time as it needed freezing thawing cycles. New researches saying that lyophilized human platelet lysate (LHPL) can be an effective alternate as it can be stored and reconstituted without zoonotic infections. So we have formulated this study so as to evaluate the potency of LHPL in fulfilling the ISCT criteria on proliferation, tri-lineage differentiation and on secretomes as a supplement in culturing hUCT-MSCs.
- Open Access
- 15 April 2025
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 12 (2) , 177-189
AI innovations in anaesthesia: A systematic review of clinical application
AI innovations in anaesthesia: A systematic review of clinical application - IJCA- Print ISSN No: - 2394-4781 Online ISSN No:- 2394-4994 Article DOI No:- 10.18231/j.ijca.2025.032, Indian Journal of Clinical Anaesthesia-Indian J Clin Anaesth
- 15 April 2025
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 12 (2) , 177-189
Open AccessAI innovations in anaesthesia: A systematic review of clinical application
AI innovations in anaesthesia: A systematic review of clinical application - IJCA- Print ISSN No: - 2394-4781 Online ISSN No:- 2394-4994 Article DOI No:- 10.18231/j.ijca.2025.032, Indian Journal of Clinical Anaesthesia-Indian J Clin Anaesth
- Open Access
- 5 December 2023
- Published by Springer Nature in Nutrition & Diabetes
- Vol. 13 (1) , 1-7
Geraniol reverses obesity by improving conversion of WAT to BAT in high fat diet induced obese rats by inhibiting HMGCoA reductase
Objectives: Present report evaluates the protective effect of geraniol on high fat diet (HFD) induced obesity in rats and also determines the molecular mechanism of it. Methods: Rats were induced with obesity with administration of HFD for four weeks and geraniol 200 and 400 mg/kg p.o. was administered for the next four week in the respective groups. Blood glucose and oral glucose tolerance test (OGTT), lipid profile was estimated in the geraniol treated HFD induced obesity in rats. Moreover, docking study was performed to determine the specific mechanism of geraniol by targeting HMG-CoE A reductase (in silico). Results: There was significant increase in body weight and amelioration in altered serum glucose and lipid profile were observed in the geraniol treated group than negative control group. Weight of organs and adipose tissue isolated from different regions of the body was reduced in geraniol treated group than negative control. Moreover, geraniol interact with HMG-CoA reductase having binding energy −5.13. Conclusions: In conclusion, data of the report reveals that geraniol reduces obesity by promoting the conversion of white adipose tissue (WAT) to brown adipose tissue (BAT), as it interacts with HMG-CoA reductase in HFD induced obesity in rats.
- 5 December 2023
- Published by Springer Nature in Nutrition & Diabetes
- Vol. 13 (1) , 1-7
Open AccessGeraniol reverses obesity by improving conversion of WAT to BAT in high fat diet induced obese rats by inhibiting HMGCoA reductase
Objectives: Present report evaluates the protective effect of geraniol on high fat diet (HFD) induced obesity in rats and also determines the molecular mechanism of it. Methods: Rats were induced with obesity with administration of HFD for four weeks and geraniol 200 and 400 mg/kg p.o. was administered for the next four week in the respective groups. Blood glucose and oral glucose tolerance test (OGTT), lipid profile was estimated in the geraniol treated HFD induced obesity in rats. Moreover, docking study was performed to determine the specific mechanism of geraniol by targeting HMG-CoE A reductase (in silico). Results: There was significant increase in body weight and amelioration in altered serum glucose and lipid profile were observed in the geraniol treated group than negative control group. Weight of organs and adipose tissue isolated from different regions of the body was reduced in geraniol treated group than negative control. Moreover, geraniol interact with HMG-CoA reductase having binding energy −5.13. Conclusions: In conclusion, data of the report reveals that geraniol reduces obesity by promoting the conversion of white adipose tissue (WAT) to brown adipose tissue (BAT), as it interacts with HMG-CoA reductase in HFD induced obesity in rats.